Literature DB >> 30705841

A novel biomarker protein panel for lung cancer, a promising first step.

Camilo Molina-Romero1, Edgar Vergara1, Oscar Arrieta1.   

Abstract

Entities:  

Year:  2018        PMID： 30705841      PMCID： PMC6328683          DOI： 10.21037/tlcr.2018.12.09

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  25 in total

Review 1.  Lung cancer biomarkers: FISHing in the sputum for risk assessment and early detection.

Authors:  Brigitte N Gomperts; Avrum Spira; David E Elashoff; Steven M Dubinett
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

2.  The National Lung Screening Trial: overview and study design.

Authors:  Denise R Aberle; Christine D Berg; William C Black; Timothy R Church; Richard M Fagerstrom; Barbara Galen; Ilana F Gareen; Constantine Gatsonis; Jonathan Goldin; John K Gohagan; Bruce Hillman; Carl Jaffe; Barnett S Kramer; David Lynch; Pamela M Marcus; Mitchell Schnall; Daniel C Sullivan; Dorothy Sullivan; Carl J Zylak
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

3.  Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.

Authors:  Dean E Brenner; Daniel P Normolle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-10       Impact factor: 4.254

Review 4.  The state of molecular biomarkers for the early detection of lung cancer.

Authors:  Mohamed Hassanein; J Clay Callison; Carol Callaway-Lane; Melinda C Aldrich; Eric L Grogan; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-11

5.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

Review 6.  Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.

Authors:  Linda L Humphrey; Mark Deffebach; Miranda Pappas; Christina Baumann; Kathryn Artis; Jennifer Priest Mitchell; Bernadette Zakher; Rongwei Fu; Christopher G Slatore
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

7.  The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Authors:  Steven M Teutsch; Linda A Bradley; Glenn E Palomaki; James E Haddow; Margaret Piper; Ned Calonge; W David Dotson; Michael P Douglas; Alfred O Berg
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

Review 8.  The EGAPP initiative: lessons learned.

Authors: 
Journal:  Genet Med       Date:  2013-08-08       Impact factor: 8.822

9.  Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis.

Authors:  Oscar Arrieta; David Saavedra-Perez; Roberto Kuri; Alejandro Aviles-Salas; Luis Martinez; Daniel Mendoza-Posada; Patricia Castillo; Alma Astorga; Enrique Guzman; Jaime De la Garza
Journal:  BMC Cancer       Date:  2009-04-22       Impact factor: 4.430

10.  Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges.

Authors:  Anna K Füzéry; Joshua Levin; Maria M Chan; Daniel W Chan
Journal:  Clin Proteomics       Date:  2013-10-02       Impact factor: 3.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.